Gossamer Bio, Inc. (GOSS)
Pharmaceutical Preparations
Latest Price
$10.70
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.24
P/B Ratio
44.73
Institutional Ownership
74.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 40.96M | $6.0M | 8.38% | +40.57M | 2026-06-30 |
| 683 Capital Management, LLC | 39.20M | $6.0M | 8.02% | +34.20M | 2026-06-30 |
| DeepCurrents Investment Group LLC | 37.67M | $6.0M | 7.70% | +37.66M | 2026-06-30 |
| Context Capital Management, LLC | 28.95M | $4.0M | 5.92% | -- | 2026-06-30 |
| Worth Venture Partners, LLC | 25.02M | $4.0M | 5.12% | -- | 2026-06-30 |
| AQR CAPITAL MANAGEMENT LLC | 15.63M | $2.0M | 3.20% | +5.50M | 2026-06-30 |
| GSA CAPITAL PARTNERS LLP | 14.99M | $2.0M | 3.07% | +11.73M | 2026-06-30 |
| WOLVERINE ASSET MANAGEMENT LLC | 12.89M | $2.0M | 2.64% | +12.89M | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 11.63M | $1.0M | 2.38% | +10.41M | 2026-06-30 |
| Kalehua Capital Management LLC | 11.15M | $1.0M | 2.28% | +3.68M | 2026-06-30 |